Activity of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymphoma.

被引：0
|
作者：
Younes, A [1 ]
McLaughlin, P [1 ]
Pro, B [1 ]
Hagemeister, FB [1 ]
Fayad, L [1 ]
Romaguera, J [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4722
引用
收藏
页码：296B / 296B
页数：1
相关论文
共 50 条
  • [1] Gemcitabine as single agent in the treatment of relapsed and refractory Hodgkin's and non-Hodgkin lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Ruestow, P
    [J]. BLOOD, 2003, 102 (11) : 285B - 285B
  • [2] Concurrent chemotherapy and radiotherapy (CRT) in relapsed or refractory non-Hodgkin's lymphoma.
    Lapusan, S
    Ribrag, V
    Driss, B
    Vantelon, SM
    Fermé, C
    Bourhis, JH
    Girinsky, T
    [J]. BLOOD, 2001, 98 (11) : 243B - 244B
  • [3] Two consecutive phase II studies of oxaliplatin based salvage chemotherapy for treatment of patients with refractory or relapsed non-Hodgkin's lymphoma.
    Delmas-Marsalet, B
    Gumus, Y
    Misra, S
    Goldschmidt, E
    Frenoy, N
    Guettier, C
    Brahimi, N
    Ulusakarya, A
    Jasmin, C
    Machover, D
    [J]. BLOOD, 2002, 100 (11) : 297B - 297B
  • [4] Autologous stem cell transplantation in patients with refractory and/or relapsed low grade non-Hodgkin's lymphoma.
    Mallidi, PV
    Qazilbash, MH
    Devetten, MP
    Beall, CL
    Weisenborn, R
    Bunner, P
    Ericson, SG
    [J]. BLOOD, 2001, 98 (11) : 394B - 394B
  • [5] Allogeneic transplantation with PBPC is an effective option for relapsed/refractory non-Hodgkin's lymphoma.
    Tarella, C
    Caracciolo, D
    Corradini, P
    Allione, B
    Novarino, A
    Van Lint, T
    Bacigalupo, A
    Locatelli, F
    Falda, M
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S163 - S163
  • [6] Reduced-intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin and non-Hodgkin lymphoma.
    Lerner, D
    Azevedo, AM
    Colares, M
    de Cássia, R
    Tavares, B
    Maradei, SC
    Lima, J
    Lobo, AMG
    Tabak, DG
    Urago, K
    Lima, MC
    Maiolino, A
    Bouzas, LFS
    [J]. BLOOD, 2005, 106 (11) : 443B - 443B
  • [7] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    [J]. CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [8] Phase II study of oxaliplatin in patients with relapsed or refractory non-Hodgkin's lymphoma: Final results.
    Oki, Y
    McLauhlin, P
    Pro, B
    Hagemeister, FH
    Bleyer, A
    Loyer, E
    Younes, A
    [J]. BLOOD, 2004, 104 (11) : 684A - 684A
  • [9] Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL).
    Davids, Matthew Steven
    Roberts, Andrew Warwick
    Seymour, John Francis
    Wierda, William G.
    Puvvada, Soham D.
    Gressick, Lori A.
    Alter, Debbie
    Zhou, Lang
    Kim, Su Young
    Verdugo, Maria
    Gerecitano, John F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] VENETOCLAX (VEN) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (NHL)
    Davids, M. S.
    Roberts, A. W.
    Seymour, J. F.
    Wierda, W. G.
    Puvvada, S. D.
    Gressick, L.
    Alter, D.
    Zhou, L.
    Kim, S. Y.
    Verdugo, M.
    Gerecitano, J. F.
    [J]. HAEMATOLOGICA, 2017, 102 : 218 - 219
12345